Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

PolyOne Names Dr. David A. Jarus as Vice President, Research and Development

AVNT

PR Newswire

CLEVELAND, April 23, 2018 /PRNewswire/ -- PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced that Dr. David A. Jarus has been appointed vice president, research and development. Dr. Jarus replaces Dr. Christopher J. Murphy who is retiring in July, after an accomplished 33-year career in the specialty chemicals industry.

In this role, Dr. Jarus will have global responsibility for driving innovation and developing new solutions and applications across all markets by collaborating with PolyOne's technical teams, corporate marketing group, business units, and external technology resources and institutions. 

Dr. Jarus joined PolyOne in 2000 as an advanced R&D scientist and has progressively earned increasing responsibility in leadership positions spanning PolyOne businesses and corporate R&D. He has served as PolyOne's M&A technology integration lead, program director of lean innovation, and global technology director for Specialty Engineered Materials. Dr. Jarus has deep polymer technical knowledge, and holds a Bachelor of Science in Chemical Engineering, a Master of Science in Macromolecular Science, and a Ph.D. in Polymers, all from Case Western Reserve University.  He also earned an MBA from John Carroll University and is a certified Lean Six Sigma black belt.  

"Innovation is the lifeblood of a specialty organization, and David has demonstrated consistent, collaborative leadership that helped to enable our specialty transformation," said Robert M. Patterson, chairman, president and chief executive officer, PolyOne Corporation.  "As we embark on more advanced levels of innovation and growth, I'm excited that David will now be leading our research and development to deliver value to our customers and shareholders."

"At the same time, I offer my sincere thanks and appreciation to Chris Murphy, who has had a tremendous career in specialty chemicals and contributed immensely to PolyOne and our customers over the last six years," Mr. Patterson added.  "We wish him all the best in retirement."

At its upcoming Investor Day on May 10, 2018, PolyOne plans to present details about technology innovation as it pertains to several high-growth focus areas that underpin the company's expectation of delivering double digit EPS growth in 2018 and beyond.  In addition, participants will have the opportunity to meet Dr. Jarus, who will be in attendance.

About PolyOne

PolyOne Corporation (NYSE:POL), with 2017 revenues of $3.2 billion, is a premier provider of specialized polymer materials, services and solutions. The company is dedicated to serving customers in diverse industries around the globe, by creating value through collaboration, innovation and an unwavering commitment to excellence. Guided by its Core Values, Sustainability Promise and No Surprises Pledge(SM), PolyOne is an ACC Responsible Care® certified company committed to its customers, employees, communities and shareholders through ethical, sustainable and fiscally responsible principles. For more information, visit www.polyone.com.

Forward-looking Statements

In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. They use words such as "will," "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: our ability to identify and evaluate acquisition targets and consummate acquisitions; the ability to successfully integrate acquired businesses into our operations, such as IQAP Masterbatch, Mesa, Rutland, Comptek, SilCoTec, Gordon Composites and Polystrand, including whether such businesses will be accretive, retain the management teams of acquired businesses, and retain relationships with customers of acquired businesses; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding the disposal of plastic in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions and employee productivity goals; an inability to raise or sustain prices for products or services; our ability to continue to pay cash dividends, including at the increasing rate, which will be subject to, among other factors, market conditions, our cash flow and cash requirements and restrictions contained in any of our debt agreements; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. The above list of factors is not exhaustive.

We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.

To access PolyOne's news library online, please go to www.polyone.com/news 

 

Cision View original content:http://www.prnewswire.com/news-releases/polyone-names-dr-david-a-jarus-as-vice-president-research-and-development-300634787.html

SOURCE PolyOne Corporation



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today